Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. - Wikidata - wikimedia - TriplyDB

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.

http://www.wikidata.org/entity/Q43619440

about

HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells Current status of novel antifibrotic therapies in patients with chronic liver disease Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis.Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia.Preliminary experimental study of urethral reconstruction with tissue engineering and RNA interference techniques.Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1 Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice Biological Significance of Local TGF-β Activation in Liver Diseases.Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis.Targeted treatments for cirrhosis.Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells.Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.Anti-TGF-beta strategies for the treatment of chronic liver disease.Emerging therapies for liver fibrosis.Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen in Schistosomiasis japonica mice with liver fibrosis The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosis Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.Matrix metalloproteinase gene delivery for liver fibrosis Pancreatic stellate cells: new target in the treatment of chronic pancreatitis.Advances in antifibrotic therapy.Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.The antifibrotic effect of a serine protease inhibitor in the kidney.Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis.Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice.Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling.Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis.TGF-beta1 gene silencing for treating liver fibrosis.Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.Signal transduction in alcohol-related diseases.

P2860

Q24308693-720CE8C8-AEE9-42B4-9FC2-2F3513AD0B8D Q24792944-20D57E25-1DD5-48CE-8CAC-2F27CDC84BD3 Q28303698-139D3031-BC6C-4124-A8AB-1941268A4640 Q28575592-31AD9268-6AFA-4347-978C-E0348F4E48E6 Q30473375-7383F70C-6CBD-4F9D-8698-E717C908BCD6 Q30828361-7C0CD5FC-68EE-4589-B180-23FA497B4291 Q31158693-C0AC9053-E468-4121-B145-E76FB8D4DE4E Q33662935-D2910771-A7A8-43D0-BD7A-428A7193BEC9 Q34256849-8B849936-F102-4F0C-BE64-F21651B6DC6E Q34642580-1C880363-58D0-40F4-A4AC-CB7F54ED263E Q35070050-49BFE1DD-AEC3-49AB-963A-B311CEEF4B7E Q35588868-FE237258-E03D-4900-9847-038B43B547E5 Q35750103-A654692E-475C-4C24-8C7D-D78E19546025 Q35781449-8EE93D7B-B924-4525-8116-F31E40EE0DF6 Q35911123-9CDB31AD-C32A-481A-8EA0-0C0B6141723E Q36020916-EB2C0FFA-831E-431E-8E8C-C76133F245A1 Q36308136-D1DE9D6C-3F3E-4A02-BBAD-B0073E59EB5B Q36308844-69581EA0-B046-4E45-B632-5F579FCCA94D Q36323627-A10395B3-4620-430A-9644-AF952BFD960B Q36339566-647BC927-0671-4A79-8C21-89F0DF039CC0 Q36478124-1194DC76-E57C-43DE-925A-482FB33EACC3 Q36506319-CCE20048-54F7-4C0C-87A9-A115D5C21F5F Q36663411-F8E6CBB4-778C-4424-9BB2-24EB16CB7B13 Q36736835-2D431CFE-19E4-46F4-9986-7E11949DADEB Q36847591-72554938-6223-4496-AB0E-77AF0C33792F Q36852793-C1F8468A-8109-4A90-97BB-1F580D61CFD4 Q36998028-D1CC3D17-337D-433D-AE82-53F54733BD23 Q37353099-ED110420-1951-43A3-9D90-3D8F3CF08D66 Q37415689-3BDE4041-77C9-49AC-A9EB-E07A7EC25646 Q39148597-F59D46C8-E237-4472-BED4-2B54ED413B95 Q39236344-AA6D9DEC-7AB6-4D51-8656-50088B877AB1 Q39586742-15600E23-1375-43DB-8DE5-9AE4BE2B8914 Q40204147-2276AFDB-7087-4C7B-9C11-D8EB5652AAB0 Q41775019-50B62CC6-8F42-4DC9-A098-AD27CF1FB68A Q41890914-AECF4D22-9850-41F5-B2DA-23ACB89FE30D Q41943203-DD8F6EDB-AD90-4393-B7E8-CD2551549312 Q42215330-2871244F-975B-4C4D-8094-867F50C9BD55 Q42591676-9D54BE0A-CF9F-48C5-8174-5F34D4576E69 Q42968161-0184C167-DD43-486B-9E25-31901F11D1A6 Q46641842-61B73220-52F0-4703-9FE7-7D8004001C36

P2860

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.

http://www.wikidata.org/entity/Q43619440

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@en

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@nl

type

label

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@en

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@nl

prefLabel

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@en

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@nl

P1433

Q43619440-D21D72EF-AA25-4C5F-9D27-57501F80757A

P1476

Q43619440-20C2A3B4-1C5B-4718-8ACC-AF0A8ED09736

P2093

Q43619440-24286BF7-886B-473F-BD97-60E11DF90BA3

Q43619440-4D02A239-D72E-409C-9E7E-3380D15BC02A

Q43619440-5A48D67D-0531-4BBB-A673-20E63E03CBC4

Q43619440-5F6D8409-9DDB-4C86-8055-DFF519CC92CC

Q43619440-83AB4306-E8AC-4F39-A94F-0454AB346A57

Q43619440-C7FF257F-8701-4B94-B5DB-B8842C92C2CE

Q43619440-E062F7C8-C5CD-4239-94BD-5BB00B062927

P304

Q43619440-D3A60140-63EB-410F-8D8C-115162DD38EC

P31

Q43619440-F4744E4F-BB58-404E-8347-71BECE93EAC1

P356

Q43619440-545548CB-6BD9-48A6-BB85-752D5970CBF3

P407

Q43619440-2FF463C3-1AE4-4C2C-ABD2-A1146AFF0B85

P433

Q43619440-0ACCD745-B7DF-4815-AE96-A2753F5A94B4

P478

Q43619440-A2EDE120-F0E6-4D56-8FA6-31EF111408B2

P50

Q43619440-2B2F3BD7-B7EE-4D55-AC20-6D5808E04016

P577

Q43619440-CD381C57-46FE-4212-855B-0E80DE48720B

P698

Q43619440-27AD4D66-3CCB-43FB-B466-D54C9BEA808B

P356

GAST.2001.24832

P1433

Gastroenterology

P1476

Prevention of rat hepatic fibr ...... generation of active TGF-beta.

@en

P2093

Akita K

http://www.w3.org/2001/XMLSchema#string

Ikeda K

http://www.w3.org/2001/XMLSchema#string

Kaneda K

http://www.w3.org/2001/XMLSchema#string

Kawada N

http://www.w3.org/2001/XMLSchema#string

Moriwaki H

http://www.w3.org/2001/XMLSchema#string

Okuno M

http://www.w3.org/2001/XMLSchema#string

Suzuki Y

http://www.w3.org/2001/XMLSchema#string

P304

1784-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/GAST.2001.24832

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11375959

http://www.w3.org/2001/XMLSchema#string